Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODYSSEI Study of istradefylline and dyskinesia onset in Parkinson's disease
jRCTs071180014Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label trial of Istradefylline in Parkinson's disease (PD) (2 arms), sponsored by Kyowa Kirin. Primary endpoint: Time to onset of dyskinesia. Started Mar 2017; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCTs071180014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180014.